In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2

Clinical and Experimental Metastasis

Volumn 18, Issue 3, 2000, Pages 239-244

  Lakka, Sajani S ^a   Konduri, Santhi D ^a   Mohanam, Sanjeeva ^a   Nicolson, Garth L ^b   Rao, Jasti S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b INSTITUTE FOR MOLECULAR MEDICINE   (United States)

Author keywords

Invasion; Lung cancer; TFPI 2

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PLACENTA PROTEIN 5;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; GENE CONSTRUCT; HUMAN; HUMAN CELL; LUNG CANCER; METASTASIS; NORTHERN BLOTTING; PROTEIN DETERMINATION; RNA ANALYSIS; WESTERN BLOTTING;

BLOTTING, NORTHERN; DNA, ANTISENSE; DNA, COMPLEMENTARY; GLYCOPROTEINS; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; PREGNANCY PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035057183     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006755223357     Document Type: Article

References (36)

1. Plasminogen activators, tissue degradation and cancer
2. The receptor for uPA: Stromal cell involvement in extracellular proteolysis during cancer invasion
3. Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo
4. Autocrine saturation of prourokinase receptors on human A431 cells
5. The plasminogen activation system and its role in lung cancer. A review
6. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs
7. Cancer cells overexpress mRNA of urokinase type plasminogen activator, its receptor and inhibitors in human non-small cell lung cancer tissue: Analysis by northern blotting and in situ hybridization
8. Prognostic impact of urokinase, urokinase receptor and type I plasminogen activator inhibitor in squamous and large cell lung cancer tissue
9. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis
10. Molecular cloning, expression and partial characterization of a second human tissue-factorpathway inhibitor
11. Extracellular matrix-associated serine protease inhibitors (M 33,000, 31,000 and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2
12. cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: Identification as placental protein 5 and tissue factor pathway inhibitor-2
13. Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis
14. HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI
15. Recombinant human tissue factor pathway inhibitor as a possible anticoagulant targeting hepatic sinusoidal walls
16. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
17. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
18. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
19. Modulation of in vitro invasion of human glioblastoma cells by urokinase type plasminogen activator receptor antibody
20. Effect of epidermal growth factor on glioma cell growth, migration and invasion in vitro
21. Biology and biochemistry of proteinases in tumor invasion
22. Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix associated serine protease inhibitor
23. The plasminogen-plasmin system in malignancy
24. Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-1 and subsequent effects on extracellular matrix-degradation
25. Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines
26. Identification of oneand-two-chain forms of trypsinogen 1 produced by a human gastric adenocarcinoma cell line
27. Quantification and characterization of human endothelial cell derived tissue factor pathway inhibitor-2
28. Novel extracellular matrix associated serine proteinase inhibitors from human skin fibroblasts
29. Lack of plasminogen activator inhibitoreffect in a transgenic mouse model of metastatic melanoma
30. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibiton
31. Tissue factor-dependent VEGF production by human fibroblasts in response to activated factor VII
32. Enhanced expression of urokinase receptor induced through the tissue factor VIIa pathway in human pancreatic cancer
33. Expression of tissue factor correlates with grade of malignancy in human glioma
34. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease
35. Expression of tissue factor by human melanoma cells promotes efficient hematogenous metastasis
36. The angiogenic effects of tissue factor on tumors and wounds